Beloranib
Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers
Zafgen · Phase 1 · Completed · Enrollment 25
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Normal Saline | n/r | n/r | n/r | n/r |
| ZGN-433 | n/r | n/r | n/r | n/r |
Not shown
- Normal Saline: endpoint not reported
- ZGN-433: endpoint not reported